Covid research helped Swiss response, says Science Foundation
The National Science Foundation's CHF45 million ($45.8 million) support to Covid-19 research in Switzerland has made an important contribution to tackling the pandemic so far, it saidExternal link on Tuesday.
This content was published on
2 minutes
RTS/jc
Despite high pressure and sometimes difficult working conditions, researchers have presented impressive results, said epidemiologist Marcel Salathé of the Federal Technology Institute Lausanne (EPFL) who chairs the steering committee of the National Research Programme “Covid-19”. This programme includes 200 researchers involved in 28 projects with a total of CHF20 million.
In the early phase of the pandemic, epidemiological and monitoring projects provided important findings on the transmissibility of the virus, mobility patterns of the population during the partial lockdown, and degree of acceptance of restrictions, which allowed the Swiss government to adapt its recommendations, says the Science Foundation.
Another early milestone was the development of an inexpensive mass test by EPFL researchers which made it possible for the first time to detect Covid-19-specific antibodies in broad population groups, including in kindergartens.
It says EAWAGExternal link wastewater monitoring, which measures the concentration of Covid-19 viruses in water bodies, was a “resounding success” and has now been extended to over a hundred sites.
Important findings in the biomedical field include effects of the virus on children, on the mental and cognitive health of adults, and recognition of Long Covid as a health problem that is still not sufficiently understood, according to the press release.
Results from tests on Covid-19 patients of drugs originally developed for other diseases were more mixed. Although there were some “successful approaches”, some studies were also discontinued “as the strategies pursued proved ineffective”, says the science foundation.
Ongoing research includes the development of new vaccines and a nasal spray vaccine for Covid-19.
Pro-Palestine uni protests to be debated in Swiss parliament
This content was published on
The Swiss People’s Party says it will launch two postulates calling for clarifications about the recent student protests and occupations.
This content was published on
A 36-year-old man from Ticino lost his life on Saturday in Val Malvaglia, in the north of canton Ticino, during a wingsuit jump from a plane.
Swiss Evangelical Reformed Church numbers dropping in French-speaking Switzerland
This content was published on
As in German-speaking Switzerland, the number of members of the Reformed Church in French-speaking Switzerland is also declining.
Gotthard traffic queue hits 20km during holiday weekend
This content was published on
The traffic jam at the Gotthard north portal reached a length of 20 kilometres on the motorway between canton Nidwalden and canton Uri.
Swiss Interior Minister visits Cannes Film Festival
This content was published on
Swiss Interior Minister left the Cannes Film Festival on Saturday after three days of intensive dialogue, meetings and film screenings.
Swiss theatre director breaks with tradition at Vienna’s Rathausplatz
This content was published on
With the proclamation of the "Free Republic of Vienna", the start of the festival on Friday evening was unusually political.
Swiss and German virologists raise hopes of nasal coronavirus vaccine
This content was published on
Swiss and German virologists working on a nasal vaccine for Covid-19 say such a technique could be much more effective against the virus.
Swiss researchers discover antibody signature that could predict Long Covid
This content was published on
Immunologists in Zurich found lower levels of two types of immunoglobulins in patients who developed post-acute Covid-19 syndrome.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.